AstraZeneca reported 5.76B in Cash and Equivalent for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Abbvie ABBV:US $ 6098M 3648M
Alcon AG ALC:SW 961M 614M
Amgen AMGN:US $ 6528M 1461M
Artemis Alpha ATS:LN 7.15M 672K
AstraZeneca AZN:LN 5762M 567M
AstraZeneca AZN:SS SK 5762M 567M
Astrazeneca AZN:US $ 5762M 567M
Bayer BAYN:GR € 5785M 1221M
Biogen BIIB:US $ 1749.3M 512.1M
Bristol Myers Squibb BMY:US $ 12369M 1610M
Eli Lilly And LLY:US $ 2459.2M 1359.3M
Fresenius FRE:GR € 2077M 1146M
Fresenius Medical Care FME:GR € 1173.34M 616.82M
Genmab GEN:DC DK 9071M 114M
Gilead Sciences GILD:US $ 4296M 1042M
GlaxoSmithKline GSK:LN 10967M 6693M
GRIFOLS GRF:SM € 397.86M 16.88M
Hikma Pharmaceutical HIK:LN 22M 20M
Lonza Group LONN:SW 1.58B 1.08B
Merck MRK:GR € 1339M 560M
Merk MRK:US $ 8556M 460M
Novartis NOVN:VX SF 13852M 1445M
Orion ORNBV:FH € 258.7M 42M
Pfizer PFE:US $ 2470M 526M
Philips PHIA:NA € 1445M 858M
Recordati REC:IM € 261.43M 16.85M
Regeneron Pharmaceuticals REGN:US $ 3345.7M 460.1M